An open-label, multicenter, extension study to evaluate the safety and efficacy of Padsevonil as adjunctive treatment of focal-onset seizures in adult subjects with drug-resistant epilepsy.

  • O'Brien, Terence (Primary Chief Investigator (PCI))
  • Perucca, Piero (Chief Investigator (CI))
  • D'Souza, Wendyl Jude (Chief Investigator (CI))
  • Berkovic, Samuel F. (Chief Investigator (CI))
  • Wijayath, Manori (Chief Investigator (CI))
  • Carney, Patrick (Chief Investigator (CI))
  • Seneviratne, Udaya (Chief Investigator (CI))
  • Reutens, David C. (Chief Investigator (CI))
  • Zentner, Christian (Chief Investigator (CI))
  • Frasca, Joseph (Chief Investigator (CI))
  • Nikpour, Armin (Chief Investigator (CI))

Project: Research

Project Details

Effective start/end date4/06/1931/12/21


  • Neurological disorders
  • Epilepsy
  • Clinical trial